reference/36096376

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36096376

Outgoing Links

Predicate	Object
contentType	Systematic Review\|Meta-Analysis\|Journal Article
endingPage	44
issn	0143-3334 1460-2180
issueIdentifier	1-2
pageRange	35-44
publicationName	Carcinogenesis
startingPage	35
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2151b9f5a6f6895b47bdb33d6db7487 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fe3a244215f7b7b9cde22ec4f8a46e62
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8a53ccc788d775d4b31f3259c0f6466f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation	Rajanala SH, Plym A, Vaselkiv JB, Ebot EM, Matsoukas K, Lin Z, Chakraborty G, Markt SC, Penney KL, Lee GM, Mucci LA, Kantoff PW, Stopsack KH. SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Carcinogenesis. 2024 Feb 12;45(1-2):35–44. PMID: 37856781; PMCID: PMC10859730.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ae9575cd8061f3981b4d04feca94a06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_426307d31431900d947d3e0f3f7eada2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ae2a98d2646ce938779c2a8cae7b5a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0722-1311 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b21e344d418abd027c892e3ad1a90af0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9221c35e4aba1f78f80d458d6e1dc0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9dd6a370fa67b9e4e7acdf123a3873b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dda8b0af291392f9c3b1895ac7d8957 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739ee44608bf4d108e3499eacdf3019b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e918577ce09c1bacf9f96265f4916e27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd61cf5528ebe5b7a352bb8241b1c10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc7680257d6c9062cf1e2fd471250bac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcbff8c8680f9379141e70939e948da9
date	2023-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/37856781 https://pubmed.ncbi.nlm.nih.gov/PMC10859730 https://doi.org/10.1093/carcin/bgad075
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2665 https://portal.issn.org/resource/ISSN/0143-3334 https://portal.issn.org/resource/ISSN/1460-2180
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis
discusses	http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0419315 http://id.nlm.nih.gov/mesh/M000626958 http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0001106 http://id.nlm.nih.gov/mesh/M0076804 http://id.nlm.nih.gov/mesh/M0368795
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019161Q000627 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D027361Q000235 http://id.nlm.nih.gov/mesh/D011471Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000728 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000074542Q000235 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D000074542Q000627 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11309 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001138684 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28234 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_062818

Total number of triples: 65.